Myasthenia gravis treatment in the elderly presents with a significant iatrogenic risk: a multicentric retrospective study-Reference-Cited by-同舟云学术

Myasthenia gravis treatment in the elderly presents with a significant iatrogenic risk: a multicentric retrospective study

Published:2023-08-17 Issue:12 Volume:270 Page:5819-5826
ISSN:0340-5354
Container-title:Journal of Neurology
language:en
Short-container-title:J Neurol

Author:

Chanson Jean-Baptiste^ORCID,Bouhour Françoise,Aubé-Nathier Anne-Catherine,Mallaret Martial,Vial Christophe,Hacquard Aurélien,Petiot Philippe,Spinazzi Marco,Nadaj-Pakleza Aleksandra,Echaniz-Laguna Andoni

Publisher

Springer Science and Business Media LLC

Subject

Neurology (clinical),Neurology

Link

https://link.springer.com/content/pdf/10.1007/s00415-023-11925-6.pdf

Reference41 articles.

1. Narayanaswami P, Sanders DB, Wolfe G et al (2021) International consensus guidance for management of myasthenia gravis: 2020 update. Neurology 96:114–122. https://doi.org/10.1212/WNL.0000000000011124

2. Gilhus NE, Verschuuren JJ (2015) Myasthenia gravis: subgroup classification and therapeutic strategies. Lancet Neurol 14:1023–1036. https://doi.org/10.1016/S1474-4422(15)00145-3

3. Fan L, Ma S, Yang Y et al (2018) Clinical differences of early and late-onset myasthenia gravis in 985 patients. Neurol Res. https://doi.org/10.1080/01616412.2018.1525121

4. Suzuki S, Utsugisawa K, Nagane Y et al (2011) Clinical and immunological differences between early and late-onset myasthenia gravis in Japan. J Neuroimmunol 230:148–152. https://doi.org/10.1016/j.jneuroim.2010.10.023

5. Christensen PB, Jensen TS, Tsiropoulos I et al (1993) Incidence and prevalence of myasthenia gravis in western Denmark: 1975 to 1989. Neurology 43:1779–1783

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiple drugs;Reactions Weekly;2024-02-10